Laurus Labs Invests ₹400 Million In Laurus Bio Subsidiary

Laurus Labs Ltd. on Thursday said it has invested ₹399.99 million in its subsidiary Laurus Bio Pvt. Ltd. by acquiring 15,414 Series A2 compulsorily convertible preference shares on a private placement-cum-preferential allotment basis, according to a filing with the exchanges.

Back in December, the company announced that Eight Roads Ventures and F-Prime Capital would invest ₹1.2 billion in Laurus Bio. At the time, Laurus Labs had also committed to co-invest ₹400 million at the same valuation. Both Laurus Labs and Eight Roads Ventures retain the right to invest an additional ₹350 million before December. 2025.